Mevis v. Eli Lilly & Co.

220 A.D.2d 34, 642 N.Y.S.2d 677
CourtAppellate Division of the Supreme Court of the State of New York
DecidedMay 23, 1996
StatusPublished
Cited by2 cases

This text of 220 A.D.2d 34 (Mevis v. Eli Lilly & Co.) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mevis v. Eli Lilly & Co., 220 A.D.2d 34, 642 N.Y.S.2d 677 (N.Y. Ct. App. 1996).

Opinions

OPINION OF THE COURT

Sullivan, J. P.

This is a products liability action against numerous pharmaceutical manufacturers for personal injuries plaintiff allegedly sustained as a result of in útero exposure to diethylstilbestrol (DES). The parties agreed before the IAS Court that plaintiff’s cause of action accrued in Indiana and that, under the borrowing statute, the Indiana Statute of Limitations applies to this case since, facially, it is shorter than the applicable New York period of limitations. (See, e.g., Besser v Squibb & Sons, 146 AD2d 107, affd 75 NY2d 847.)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Reed v. City of Evansville
956 N.E.2d 684 (Indiana Court of Appeals, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
220 A.D.2d 34, 642 N.Y.S.2d 677, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mevis-v-eli-lilly-co-nyappdiv-1996.